A detailed history of Janus Henderson Group PLC transactions in Mimedx Group, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 73,694 shares of MDXG stock, worth $670,615. This represents 0.0% of its overall portfolio holdings.

Number of Shares
73,694
Previous 73,694 -0.0%
Holding current value
$670,615
Previous $510,000 14.71%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$6.16 - $8.08 $2,778 - $3,644
-451 Reduced 0.61%
73,694 $510,000
Q1 2024

May 15, 2024

SELL
$7.61 - $8.63 $897 - $1,018
-118 Reduced 0.16%
74,145 $570,000
Q4 2023

Feb 14, 2024

BUY
$5.7 - $9.14 $296 - $475
52 Added 0.07%
74,263 $651,000
Q3 2023

Nov 14, 2023

BUY
$6.35 - $8.16 $257,854 - $331,353
40,607 Added 120.84%
74,211 $540,000
Q2 2023

Aug 14, 2023

SELL
$3.14 - $6.61 $141 - $297
-45 Reduced 0.13%
33,604 $222,000
Q1 2023

May 15, 2023

BUY
$2.97 - $4.81 $56,055 - $90,783
18,874 Added 127.74%
33,649 $114,000
Q3 2022

Nov 14, 2022

SELL
$2.71 - $4.22 $330 - $514
-122 Reduced 0.82%
14,775 $43,000
Q2 2022

Aug 15, 2022

BUY
$3.17 - $5.0 $580 - $915
183 Added 1.24%
14,897 $51,000
Q1 2022

May 16, 2022

BUY
$4.27 - $6.27 $8 - $12
2 Added 0.01%
14,714 $69,000
Q4 2021

Feb 14, 2022

BUY
$5.7 - $8.48 $83,858 - $124,757
14,712 New
14,712 $89,000
Q4 2018

Feb 06, 2019

SELL
$1.15 - $6.45 $52,214 - $292,855
-45,404 Closed
0 $0
Q3 2018

Nov 09, 2018

BUY
$3.22 - $6.33 $91,538 - $179,949
28,428 Added 167.46%
45,404 $281,000
Q2 2018

Aug 10, 2018

BUY
$5.39 - $8.96 $1,536 - $2,553
285 Added 1.71%
16,976 $108,000
Q1 2018

May 14, 2018

BUY
$6.69 - $17.96 $14,952 - $40,140
2,235 Added 15.46%
16,691 $116,000
Q4 2017

Feb 09, 2018

BUY
$10.87 - $13.9 $157,136 - $200,938
14,456
14,456 $182,000

Others Institutions Holding MDXG

About MIMEDX GROUP, INC.


  • Ticker MDXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 113,609,000
  • Market Cap $1.03B
  • Description
  • MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary pr...
More about MDXG
Track This Portfolio

Track Janus Henderson Group PLC Portfolio

Follow Janus Henderson Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.